|
1
|
Frazzetto S, Gullo L, Sapuppo G, Fazio M, Lo Faro C, Giunta G, Caravotta I, Mauro E, Parisi MS, Triolo AM, Parrinello NL, Consoli ML, També L, Cambria D, Marino S, Scuderi G, Di Raimondo F. Three-Way Translocation t(12;15;17) (p13;q24;q21) Found in Acute Promyelocytic Leukemia with Basophilic Differentiation. Hematol Rep 2024; 16:367-374. [PMID: 38921185 PMCID: PMC11203485 DOI: 10.3390/hematolrep16020037] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/13/2024] [Revised: 05/29/2024] [Accepted: 06/07/2024] [Indexed: 06/27/2024] Open
Abstract
Acute promyelocytic leukemia is a rare form of acute myeloid leukemia in which immature promyelocytes abnormally proliferate in the bone marrow. In most cases, the disease is characterised by the translocation t(15;17) (q24;q21), which causes the formation of PML::RARA, an oncogenic fusion protein responsible for blocking myeloid differentiation and survival advantage. Here, we present a case of acute promyelocytic leukemia with two unusual features: basophilic differentiation and a three-way translocation involving chromosomes 12, 15 and 17. In the few cases reported, basophilic differentiation was associated with a poor prognosis. In contrast, our patient responded promptly to the standard treatment with all-trans-retinoic acid (ATRA) and arsenic trioxide (ATO) and obtained complete remission. To our knowledge, this is the first report of basophilic acute promyelocytic leukemia with the three-way translocation t(12;17;15) (p13; q24;q21).
Collapse
Affiliation(s)
- Sara Frazzetto
- Division of Hematology, Azienda Policlinico-San Marco, 95123 Catania, Italy; (L.G.); (G.S.); (M.F.); (C.L.F.); (G.G.); (I.C.); (E.M.); (M.S.P.); (A.M.T.); (N.L.P.); (M.L.C.); (L.T.); (D.C.); (S.M.); (G.S.); (F.D.R.)
- Postgraduate School of Hematology, University of Catania, 95123 Catania, Italy
| | - Lara Gullo
- Division of Hematology, Azienda Policlinico-San Marco, 95123 Catania, Italy; (L.G.); (G.S.); (M.F.); (C.L.F.); (G.G.); (I.C.); (E.M.); (M.S.P.); (A.M.T.); (N.L.P.); (M.L.C.); (L.T.); (D.C.); (S.M.); (G.S.); (F.D.R.)
- Postgraduate School of Hematology, University of Catania, 95123 Catania, Italy
| | - Gabriele Sapuppo
- Division of Hematology, Azienda Policlinico-San Marco, 95123 Catania, Italy; (L.G.); (G.S.); (M.F.); (C.L.F.); (G.G.); (I.C.); (E.M.); (M.S.P.); (A.M.T.); (N.L.P.); (M.L.C.); (L.T.); (D.C.); (S.M.); (G.S.); (F.D.R.)
- Postgraduate School of Hematology, University of Catania, 95123 Catania, Italy
| | - Manlio Fazio
- Division of Hematology, Azienda Policlinico-San Marco, 95123 Catania, Italy; (L.G.); (G.S.); (M.F.); (C.L.F.); (G.G.); (I.C.); (E.M.); (M.S.P.); (A.M.T.); (N.L.P.); (M.L.C.); (L.T.); (D.C.); (S.M.); (G.S.); (F.D.R.)
- Postgraduate School of Hematology, University of Catania, 95123 Catania, Italy
| | - Cristina Lo Faro
- Division of Hematology, Azienda Policlinico-San Marco, 95123 Catania, Italy; (L.G.); (G.S.); (M.F.); (C.L.F.); (G.G.); (I.C.); (E.M.); (M.S.P.); (A.M.T.); (N.L.P.); (M.L.C.); (L.T.); (D.C.); (S.M.); (G.S.); (F.D.R.)
- Postgraduate School of Hematology, University of Catania, 95123 Catania, Italy
| | - Giuliana Giunta
- Division of Hematology, Azienda Policlinico-San Marco, 95123 Catania, Italy; (L.G.); (G.S.); (M.F.); (C.L.F.); (G.G.); (I.C.); (E.M.); (M.S.P.); (A.M.T.); (N.L.P.); (M.L.C.); (L.T.); (D.C.); (S.M.); (G.S.); (F.D.R.)
- Postgraduate School of Hematology, University of Catania, 95123 Catania, Italy
| | - Ignazio Caravotta
- Division of Hematology, Azienda Policlinico-San Marco, 95123 Catania, Italy; (L.G.); (G.S.); (M.F.); (C.L.F.); (G.G.); (I.C.); (E.M.); (M.S.P.); (A.M.T.); (N.L.P.); (M.L.C.); (L.T.); (D.C.); (S.M.); (G.S.); (F.D.R.)
- Postgraduate School of Hematology, University of Catania, 95123 Catania, Italy
| | - Elisa Mauro
- Division of Hematology, Azienda Policlinico-San Marco, 95123 Catania, Italy; (L.G.); (G.S.); (M.F.); (C.L.F.); (G.G.); (I.C.); (E.M.); (M.S.P.); (A.M.T.); (N.L.P.); (M.L.C.); (L.T.); (D.C.); (S.M.); (G.S.); (F.D.R.)
| | - Marina Silvia Parisi
- Division of Hematology, Azienda Policlinico-San Marco, 95123 Catania, Italy; (L.G.); (G.S.); (M.F.); (C.L.F.); (G.G.); (I.C.); (E.M.); (M.S.P.); (A.M.T.); (N.L.P.); (M.L.C.); (L.T.); (D.C.); (S.M.); (G.S.); (F.D.R.)
| | - Anna Maria Triolo
- Division of Hematology, Azienda Policlinico-San Marco, 95123 Catania, Italy; (L.G.); (G.S.); (M.F.); (C.L.F.); (G.G.); (I.C.); (E.M.); (M.S.P.); (A.M.T.); (N.L.P.); (M.L.C.); (L.T.); (D.C.); (S.M.); (G.S.); (F.D.R.)
| | - Nunziatina Laura Parrinello
- Division of Hematology, Azienda Policlinico-San Marco, 95123 Catania, Italy; (L.G.); (G.S.); (M.F.); (C.L.F.); (G.G.); (I.C.); (E.M.); (M.S.P.); (A.M.T.); (N.L.P.); (M.L.C.); (L.T.); (D.C.); (S.M.); (G.S.); (F.D.R.)
| | - Maria Letizia Consoli
- Division of Hematology, Azienda Policlinico-San Marco, 95123 Catania, Italy; (L.G.); (G.S.); (M.F.); (C.L.F.); (G.G.); (I.C.); (E.M.); (M.S.P.); (A.M.T.); (N.L.P.); (M.L.C.); (L.T.); (D.C.); (S.M.); (G.S.); (F.D.R.)
| | - Loredana També
- Division of Hematology, Azienda Policlinico-San Marco, 95123 Catania, Italy; (L.G.); (G.S.); (M.F.); (C.L.F.); (G.G.); (I.C.); (E.M.); (M.S.P.); (A.M.T.); (N.L.P.); (M.L.C.); (L.T.); (D.C.); (S.M.); (G.S.); (F.D.R.)
| | - Daniela Cambria
- Division of Hematology, Azienda Policlinico-San Marco, 95123 Catania, Italy; (L.G.); (G.S.); (M.F.); (C.L.F.); (G.G.); (I.C.); (E.M.); (M.S.P.); (A.M.T.); (N.L.P.); (M.L.C.); (L.T.); (D.C.); (S.M.); (G.S.); (F.D.R.)
| | - Sara Marino
- Division of Hematology, Azienda Policlinico-San Marco, 95123 Catania, Italy; (L.G.); (G.S.); (M.F.); (C.L.F.); (G.G.); (I.C.); (E.M.); (M.S.P.); (A.M.T.); (N.L.P.); (M.L.C.); (L.T.); (D.C.); (S.M.); (G.S.); (F.D.R.)
| | - Grazia Scuderi
- Division of Hematology, Azienda Policlinico-San Marco, 95123 Catania, Italy; (L.G.); (G.S.); (M.F.); (C.L.F.); (G.G.); (I.C.); (E.M.); (M.S.P.); (A.M.T.); (N.L.P.); (M.L.C.); (L.T.); (D.C.); (S.M.); (G.S.); (F.D.R.)
| | - Francesco Di Raimondo
- Division of Hematology, Azienda Policlinico-San Marco, 95123 Catania, Italy; (L.G.); (G.S.); (M.F.); (C.L.F.); (G.G.); (I.C.); (E.M.); (M.S.P.); (A.M.T.); (N.L.P.); (M.L.C.); (L.T.); (D.C.); (S.M.); (G.S.); (F.D.R.)
- Postgraduate School of Hematology, University of Catania, 95123 Catania, Italy
| |
Collapse
|
|
2
|
Vivanco Gonzalez N, Oliveria JP, Tebaykin D, Ivison GT, Mukai K, Tsai MM, Borges L, Nadeau KC, Galli SJ, Tsai AG, Bendall SC. Mass Cytometry Phenotyping of Human Granulocytes Reveals Novel Basophil Functional Heterogeneity. iScience 2020; 23:101724. [PMID: 33205028 PMCID: PMC7653073 DOI: 10.1016/j.isci.2020.101724] [Citation(s) in RCA: 16] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/12/2020] [Revised: 08/18/2020] [Accepted: 10/20/2020] [Indexed: 02/06/2023] Open
Abstract
Basophils, the rarest granulocyte, play critical roles in parasite- and allergen-induced inflammation. We applied mass cytometry (CyTOF) to simultaneously asses 44 proteins to phenotype and functionally characterize neutrophils, eosinophils, and basophils from 19 healthy donors. There was minimal heterogeneity seen in eosinophils and neutrophils, but data-driven analyses revealed four unique subpopulations within phenotypically basophilic granulocytes (PBG; CD45+HLA-DR-CD123+). Through CyTOF and fluorescence-activated cell sorting (FACS), we classified these four PBG subpopulations as (I) CD16lowFcεRIhighCD244high (88.5 ± 1.2%), (II) CD16highFcεRIhighCD244high (9.1 ± 0.4%), (III) CD16lowFcεRIlowCD244low (2.3 ± 1.3), and (IV) CD16highFcεRIlowCD244low (0.4 ± 0.1%). Prospective isolation confirmed basophilic-morphology of PBG I-III, but neutrophilic-morphology of PBG IV. Functional interrogation via IgE-crosslinking or IL-3 stimulation demonstrated that PBG I-II had significant increases in CD203c expression, whereas PBG III-IV remained unchanged compared with media-alone conditions. Thus, PBG III-IV could serve roles in non-IgE-mediated immunity. Our findings offer new perspectives in human basophil heterogeneity and the varying functional potential of these new subsets in health and disease.
Collapse
Affiliation(s)
- Nora Vivanco Gonzalez
- Department of Pathology, School of Medicine, Stanford University, Stanford Blood Center, 3373 Hillview Avenue Room 230A, Palo Alto, CA 94305, USA
| | - John-Paul Oliveria
- Department of Pathology, School of Medicine, Stanford University, Stanford Blood Center, 3373 Hillview Avenue Room 230A, Palo Alto, CA 94305, USA
- Department of Medicine, Division of Respirology, McMaster University, Hamilton, ON, L8S4K1, Canada
| | - Dmitry Tebaykin
- Department of Pathology, School of Medicine, Stanford University, Stanford Blood Center, 3373 Hillview Avenue Room 230A, Palo Alto, CA 94305, USA
| | - Geoffrey T. Ivison
- Department of Pathology, School of Medicine, Stanford University, Stanford Blood Center, 3373 Hillview Avenue Room 230A, Palo Alto, CA 94305, USA
| | - Kaori Mukai
- Department of Pathology, School of Medicine, Stanford University, Stanford Blood Center, 3373 Hillview Avenue Room 230A, Palo Alto, CA 94305, USA
- Sean N. Parker Center for Allergy Research, School of Medicine, Stanford University, Palo Alto, CA 94305, USA
| | - Mindy M. Tsai
- Department of Pathology, School of Medicine, Stanford University, Stanford Blood Center, 3373 Hillview Avenue Room 230A, Palo Alto, CA 94305, USA
- Sean N. Parker Center for Allergy Research, School of Medicine, Stanford University, Palo Alto, CA 94305, USA
| | - Luciene Borges
- Department of Pathology, School of Medicine, Stanford University, Stanford Blood Center, 3373 Hillview Avenue Room 230A, Palo Alto, CA 94305, USA
| | - Kari C. Nadeau
- Sean N. Parker Center for Allergy Research, School of Medicine, Stanford University, Palo Alto, CA 94305, USA
- Department of Medicine, Division of Pulmonary and Critical Care Medicine, School of Medicine, Stanford University, Palo Alto, CA 94305, USA
| | - Stephen J. Galli
- Department of Pathology, School of Medicine, Stanford University, Stanford Blood Center, 3373 Hillview Avenue Room 230A, Palo Alto, CA 94305, USA
- Sean N. Parker Center for Allergy Research, School of Medicine, Stanford University, Palo Alto, CA 94305, USA
- Department of Microbiology and Immunology, School of Medicine, Stanford University, Palo Alto, CA 94305, USA
| | - Albert G. Tsai
- Department of Pathology, School of Medicine, Stanford University, Stanford Blood Center, 3373 Hillview Avenue Room 230A, Palo Alto, CA 94305, USA
| | - Sean C. Bendall
- Department of Pathology, School of Medicine, Stanford University, Stanford Blood Center, 3373 Hillview Avenue Room 230A, Palo Alto, CA 94305, USA
| |
Collapse
|